4-(AZETIDIN-3-YL)-2-METHYLPYRIMIDINE TRIFLUOROACETATE, 95.0%, 1g

1,3-Bis(4-hydroxybutyl)tetramethyldisiloxane, 10g

2-HYDROXY-4-(TRIFLUOROMETHYL)BENZALDEHYDE, 95.0%, 50g

(R)-(+)-N,N-Dimethyl-1-ferrocenylethylamine>98.0%(GC)200mg

5-METHOXY-1H-INDAZOLE-3-CARBOXYLIC ACID, 95%, 1g

6-Oxo-1-propyl-1,6-dihydropyridazine-3-carboxylic acid, 97%, 100mg

Ethyl 3-bromobenzoate, 95.0%, 25g

Ethyl 4-amino-3-bromo-5-fluorobenzoate, 95.0%, 1g

Boc-Lys(Boc)-Onp, 95%, 1g

6-METHYL-7-NITRO-1H-INDAZOLE, 95%, 1g

Benzyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate, 95.0%, 100mg

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

2-Phenyl-1H-imidazole, 95.0%, 25g